Myriad RBM's Focused MAPs
Myriad RBM's Focused Multi-Analyte Profiles (MAPs) structure our quantitative immunoassays into discrete services based on their role in several different therapy indications. These MAPs help researchers focus on the biomarkers relevant to the disease or therapy area being studied with a more targeted approach and smaller sample volume than our Discovery products.
| MAP | Volume Required | |
|---|---|---|
| Serum or Plasma | Other fluids * | |
| Human CardiovascularMAP® » | 200 μL | 700 μL |
| Human AngiogenesisMAP® » | 250 μL | 500 μL |
| Human InflammationMAP® » | 50 μL | 300 μL |
| Human ImmunoMAP® » | 200 μL | 650 μL |
| Human NeuroMAP™ » | 100 μL | 500 μL |
| Human KidneyMAP® » | 50 μL | 350 μL |
| Human MetabolicMAP® » | 50 μL | 300 μL |
| Human CytokineMAP® A » | 50 μL | 125 μL |
| Human CytokineMAP® B » | 50 μL | 125 μL |
*Cerebrospinal fluid, urine, tissue culture supernatants, bronchoalveolar lavage, synovial fluid, tissue extracts, tears, skin washings, etc.